Jay R. Luly
2015
In 2015, Jay R. Luly earned a total compensation of $3.6M as President and Chief Executive Officer at Enanta Pharmaceuticals, a 42% increase compared to previous year.
Compensation breakdown
| Bonus | $286,411 |
|---|---|
| Option Awards | $2,518,566 |
| Salary | $520,748 |
| Stock Awards | $225,335 |
| Other | $15,706 |
| Total | $3,566,766 |
Luly received $2.5M in option awards, accounting for 71% of the total pay in 2015.
Luly also received $286.4K in bonus, $520.7K in salary, $225.3K in stock awards and $15.7K in other compensation.
Rankings
In 2015, Jay R. Luly's compensation ranked 2,538th out of 13,638 executives tracked by ExecPay. In other words, Luly earned more than 81.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,538 out of 13,638 | 81st |
Division Manufacturing | 895 out of 5,187 | 83rd |
Major group Chemicals And Allied Products | 325 out of 1,857 | 83rd |
Industry group Drugs | 257 out of 1,531 | 83rd |
Industry Pharmaceutical Preparations | 203 out of 1,179 | 83rd |
Source: SEC filing on January 6, 2017.
Luly's colleagues
We found two more compensation records of executives who worked with Jay R. Luly at Enanta Pharmaceuticals in 2015.
News
Enanta Pharmaceuticals CEO Jay Luly's 2022 pay jumps 37% to $7.3M
January 20, 2023
Enanta Pharmaceuticals CEO Jay Luly's 2021 pay rises 2% to $5.3M
January 21, 2022
Enanta Pharmaceuticals CEO Jay Luly's 2020 pay rises 16% to $5.2M
January 21, 2021
Enanta Pharmaceuticals CEO Jay Luly's 2019 pay slips 1% to $4.5M
January 17, 2020
Enanta Pharmaceuticals CEO Jay Luly's 2018 pay rises 5% to $4.5M
January 18, 2019